Fresenius Medical Care AG

BUL:FME Stock Report

Market Cap: €11.2b

Fresenius Medical Care KGaA Past Earnings Performance

Past criteria checks 1/6

Fresenius Medical Care KGaA's earnings have been declining at an average annual rate of -16.6%, while the Healthcare industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 2% per year. Fresenius Medical Care KGaA's return on equity is 5.8%, and it has net margins of 3.5%.

Key information

-16.6%

Earnings growth rate

-15.4%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate2.0%
Return on equity5.8%
Net Margin3.5%
Next Earnings Update09 May 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Fresenius Medical Care KGaA makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BUL:FME Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2219,3986733,506229
30 Sep 2219,0487633,570234
30 Jun 2218,3938063,311225
31 Mar 2217,9578783,172222
31 Dec 2117,6199693,012221
30 Sep 2117,3729183,011205
30 Jun 2117,3449982,986198
31 Mar 2117,5811,1312,868197
31 Dec 2017,8591,1642,966194
30 Sep 2018,0391,3302,991190
30 Jun 2018,0441,3093,016187
31 Mar 2017,8321,2123,099185
31 Dec 1917,4771,2002,944168
30 Sep 1917,1961,2822,967138
30 Jun 1916,8351,2342,978122
31 Mar 1916,7041,9742,898111
31 Dec 1816,5471,9822,857114
30 Sep 1816,6761,9513,126131
30 Jun 1816,9541,9753,185133
31 Mar 1817,2111,2503,374130
31 Dec 1717,7841,2803,640111
30 Sep 1717,7711,2493,417134
30 Jun 1717,6471,2443,407145
31 Mar 1717,2011,2393,262144
31 Dec 1616,5701,1443,133147
30 Sep 1616,1011,0633,047143
30 Jun 1615,8419983,027136
31 Mar 1615,4029332,961130

Quality Earnings: FME has high quality earnings.

Growing Profit Margin: FME's current net profit margins (3.5%) are lower than last year (5.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: FME's earnings have declined by 16.6% per year over the past 5 years.

Accelerating Growth: FME's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: FME had negative earnings growth (-30.5%) over the past year, making it difficult to compare to the Healthcare industry average (-5.3%).


Return on Equity

High ROE: FME's Return on Equity (5.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/03/28 08:32
End of Day Share Price 2022/12/30 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fresenius Medical Care AG is covered by 59 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Brian WilliamsAvondale Partners
Olav ZilianBaader Helvea Equity Research